C&D’s Act May Be Hard To Follow For Drug Firms Considering Bolt-Ons
This article was originally published in The Tan Sheet
Executive Summary
Church & Dwight CEO James Craigie has a few words of wisdom on bolt-on acquisitions, recently a popular buzzword among big pharmas looking for savings